ss 31 peptide kidney SS31 protects the brain against neurodegeneration - SS-31peptidedosage SS31 protected renal tubulointerstitial injury in diabetic mice Unveiling the Potential of SS-31 Peptide in Kidney Health

SS-31peptidedosage The intricate world of cellular biology and therapeutic interventions continues to reveal innovative compounds with profound implications for human health. Among these, the mitochondria-targeting peptide SS-31, also known by its investigational names Elamipretide and Bendavia, has emerged as a significant area of research, particularly concerning its potential benefits for kidney health. This peptide's unique ability to target and positively influence mitochondria has positioned it as a promising agent in addressing various kidney diseases and injuries.

At its core, SS-31 is a small peptide that exhibits a remarkable affinity for mitochondria, the powerhouses of our cells. This targeted accumulation within the inner mitochondrial membrane allows SS-31 to exert its protective effects directly where cellular energy production and stress response mechanisms are most active.作者：MT Sweetwyne·2017·被引用次数：112—A short course ofSS-31 has protective benefits on glomerular mitochondria, accompanied by temporal changes to the glomerular architecture. Research indicates that SS-31 functions as a potent mitochondria-targeting antioxidant.Mitochondria-targeted peptide SS-31 attenuates renal ... By scavenging reactive oxygen species (ROS), it helps to mitigate oxidative stress, a key contributor to cellular damage and the progression of numerous diseases, including those affecting the kidney. This antioxidant capacity is crucial for maintaining cellular integrity and function.

The scientific literature extensively documents the nephroprotective effects of SS-31 on kidney disease. Studies demonstrate that SS-31 can significantly attenuate renal injury through its antioxidant mechanisms. For instance, in models of diabetic nephropathy, SS-31 has been shown to improve renal function by reducing oxidative stress and inflammation within the kidney tissue. This translates to tangible improvements such as a decrease in urinary albumin excretion, reduced proteinuria, and normalized serum creatinine levels, ultimately enhancing overall kidney function.2020年9月25日—SS-31is expected to play an important role in the prevention and treatment of the acuterenalinjury.SS-31can also reducerenal... Furthermore, SS-31 has been observed to reduce kidney tissue inflammation, fibrosis, and histopathological damage, offering a multifaceted approach to kidney protection.作者：D Liu·2019·被引用次数：158—Mitochondria-targeted peptide SS-31 attenuates renal injuryvia an antioxidant effect in diabetic nephropathy. Am. J. Physiol. Renal. Physiol., 310 (6) (2016).

A critical aspect of SS-31's efficacy lies in its ability to stabilize and improve mitochondrial function. In conditions such as acute kidney injury (AKI), often induced by factors like contrast agents used in medical imaging, SS-31 has demonstrated a capacity to protect the kidney by safeguarding mitochondrial function and inhibiting detrimental signaling pathways like ROS-NLRP3. This protective action extends to situations of ischemia-reperfusion injury, where SS-31 has been shown to improve kidney mitochondrial function after such events.作者：B Ravenscraft·2025·被引用次数：3—SS-31, a mitochondria-targeted peptidethat selectively binds to CL, effectively attenuated this CL loss in a dose-dependent manner. This protective effect ... By stabilizing the structure and function of mitochondria, particularly under conditions of stress or injury, SS-31 helps to preserve cellular energy production and reduce cell deathSS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney ....

The therapeutic potential of SS-31 is not limited to general kidney protection作者：JC Wyss·2019·被引用次数：22—The mitochondria-active tetrapeptide SS-31can control oxidative tissue damage in kidney diseases. To investigate other potential beneficial nephroprotective .... It has shown promise in specific disease contexts.Differential Effects of the Mitochondria-Active Tetrapeptide ... For example, research has highlighted that SS-31 can protect against the progression of diabetic nephropathy by downregulating specific cellular markers like CD36. Moreover, SS-31 has been found to control oxidative tissue damage in kidney diseases and has demonstrated protective benefits on glomerular mitochondria, leading to temporal changes in glomerular architecture. In animal models, SS-31 has been shown to protect against renal tubulointerstitial injury in conditions like diabetic mice by modulating mitochondrial dynamics and suppressing the expression of key proteins involved in mitochondrial fission.

Beyond its direct impact on the kidney, SS-31 is also being investigated for its broader therapeutic applications. It is a mitochondria-active tetrapeptide that has shown promise in conditions beyond renal health, including neurodegenerative diseases.SS31 While this article focuses on SS-31 peptide and kidney disease, its comprehensive effects are a testament to the fundamental role of mitochondrial health across various organ systems作者：B Ravenscraft·2025·被引用次数：3—SS-31, a mitochondria-targeted peptidethat selectively binds to CL, effectively attenuated this CL loss in a dose-dependent manner. This protective effect .... The peptide SS-31 is currently under clinical trials for multiple mitochondrial disorders, underscoring its significant therapeutic potential.

The mechanism of action of SS-31 involves its selective accumulation in the mitochondria, where it binds to cardiolipin (CL), a critical lipid component of the inner mitochondrial membraneSS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney .... This binding helps to preserve cardiolipin levels, which are vital for the proper functioning of the electron transport chain and ATP production. By stabilizing the mitochondrial cardiolipin-targeted tetrapeptide, SS-31 effectively preserves mitochondrial integrity and function, even under stress.作者：Q Yang·2022·被引用次数：10—SS31 is a novel tetrapeptide compoundthat targets the inner mitochondrial membrane and protects mitochondria by reducing ROS and inhibiting cardiolipin ... This leads to enhanced renal ATP production and an improved cellular energy status within the kidney.

In summary, the mitochondria-targeting peptide SS-31 represents a significant advancement in the pursuit of effective treatments for kidney ailments.2023年5月10日—SS-31 can reduce acute kidney injuryinduced by iodine contrast agent in diabetes by protecting mitochondrial function and inhibiting the ROS-NLRP3 signaling ... Its ability to target mitochondria, act as an antioxidant, and improve cellular energy metabolism provides a robust foundation for its nephroprotective effects. As research progresses and clinical trials continue, SS-31 holds considerable promise for ameliorating kidney disease and protecting against various forms of kidney injury, ultimately contributing to better patient outcomes. The exploration of SS-31 peptide benefits continues to yield exciting discoveries in the field of renal health.作者：Q Yang·2022·被引用次数：10—SS31 is a novel tetrapeptide compoundthat targets the inner mitochondrial membrane and protects mitochondria by reducing ROS and inhibiting cardiolipin ...